Qingqing Xu

4.9k total citations · 1 hit paper
244 papers, 3.8k citations indexed

About

Qingqing Xu is a scholar working on Molecular Biology, Epidemiology and Biomedical Engineering. According to data from OpenAlex, Qingqing Xu has authored 244 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 80 papers in Molecular Biology, 34 papers in Epidemiology and 32 papers in Biomedical Engineering. Recurrent topics in Qingqing Xu's work include Nanoplatforms for cancer theranostics (26 papers), Advanced Nanomaterials in Catalysis (15 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (9 papers). Qingqing Xu is often cited by papers focused on Nanoplatforms for cancer theranostics (26 papers), Advanced Nanomaterials in Catalysis (15 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (9 papers). Qingqing Xu collaborates with scholars based in China, United States and United Kingdom. Qingqing Xu's co-authors include Siling Wang, Qinfu Zhao, Shuaipeng Feng, Junya Lu, Zhaokui Jin, Qianjun He, Jianhua Jin, Shuang‐Quan Zang, Yuanzhe Lin and Thomas C. W. Mak and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and SHILAP Revista de lepidopterología.

In The Last Decade

Qingqing Xu

228 papers receiving 3.7k citations

Hit Papers

Photocatalytic glucose depletion and hydrogen generation ... 2022 2026 2023 2024 2022 25 50 75 100

Peers

Qingqing Xu
Qingqing Xu
Citations per year, relative to Qingqing Xu Qingqing Xu (= 1×) peers Xiaoying Yang

Countries citing papers authored by Qingqing Xu

Since Specialization
Citations

This map shows the geographic impact of Qingqing Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qingqing Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qingqing Xu more than expected).

Fields of papers citing papers by Qingqing Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qingqing Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qingqing Xu. The network helps show where Qingqing Xu may publish in the future.

Co-authorship network of co-authors of Qingqing Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Qingqing Xu. A scholar is included among the top collaborators of Qingqing Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qingqing Xu. Qingqing Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tian, Qi, Zhijie Li, Shengming Jiang, et al.. (2025). FOXO3a-BAP1 axis regulates neuronal ferroptosis in early brain injury after subarachnoid hemorrhage. Redox Biology. 82. 103550–103550. 3 indexed citations
2.
Chen, Wentao, Xin‐zhuan Su, Yuying Pan, et al.. (2025). Chlamydial protease-like activity factor targets SLC7A11 for degradation to induce ferroptosis and facilitate progeny releases. PLoS Pathogens. 21(4). e1013060–e1013060. 1 indexed citations
3.
Ji, Peng, et al.. (2024). Advances in nanoparticle-based therapeutics for ischemic stroke: Enhancing drug delivery and efficacy. Biomedicine & Pharmacotherapy. 180. 117564–117564. 12 indexed citations
4.
Feng, Shuaipeng, et al.. (2024). Tumor microenvironment sensitization via dual-catalysis of carbon-based nanoenzyme for enhanced photodynamic therapy. Journal of Colloid and Interface Science. 663. 577–590. 51 indexed citations
5.
Yan, Ziwei, Jinghao Chen, Qingqing Xu, et al.. (2024). Cu(II)-doped mesoporous polydopamine as biodegradable nanoplatforms for photothermal-enhanced multi-mode anti-tumor therapy. Colloids and Surfaces A Physicochemical and Engineering Aspects. 685. 133258–133258. 7 indexed citations
6.
Chen, Youjun, Wanying Wang, Jingjing Huang, et al.. (2024). The atypical antipsychotics and sexual dysfunction: a pharmacovigilance-pharmacodynamic study. Frontiers in Pharmacology. 15. 1423075–1423075. 5 indexed citations
7.
Li, Jingyuan, et al.. (2024). Transcriptome-level analysis of gene expressions in different tissues of tomato and key gene identifications during seed germination. Scientia Horticulturae. 337. 113565–113565. 5 indexed citations
8.
Xu, Qingqing, Jiali Li, Bin Liu, et al.. (2023). Biodegradable copper-doped hollow mesoporous polydopamine nanoparticles for chemo/photothermal/chemodynamic synergistic therapy. Journal of Drug Delivery Science and Technology. 89. 105015–105015. 11 indexed citations
10.
Xu, Qingqing, Yan Zhu, Xi Zhang, et al.. (2023). Clinical features and FLAIR radiomics nomogram for predicting functional outcomes after thrombolysis in ischaemic stroke. Frontiers in Neuroscience. 17. 1063391–1063391. 4 indexed citations
11.
Li, Mengyuan, Yumeng Wang, Qingqing Xu, et al.. (2023). Baicalin can enhance odonto/osteogenic differentiation of inflammatory dental pulp stem cells by inhibiting the NF-κB and β-catenin/Wnt signaling pathways. Molecular Biology Reports. 50(5). 4435–4446. 9 indexed citations
12.
Xu, Qingqing, Weifei Wang, Dongxiao Sun‐Waterhouse, et al.. (2023). The in vitro digestion fates of diacylglycerol under different intestinal conditions: a potential lipid source for lipid indigestion patients. Food Science and Human Wellness. 13(2). 1079–1092. 4 indexed citations
13.
Yang, Jia, et al.. (2022). Application of camellia oil-based diacylglycerol and its solid fractions in soft ice cream. International Food Research Journal. 29(6). 1411–1418. 1 indexed citations
14.
Li, Zhenwei, et al.. (2021). Mettl3 promotes oxLDL‐mediated inflammation through activating STAT1 signaling. Journal of Clinical Laboratory Analysis. 36(1). e24019–e24019. 30 indexed citations
15.
Qi, Baokun, et al.. (2021). Effect of salt ions on an ultrasonically modified soybean lipophilic protein nanoemulsion. International Journal of Food Science & Technology. 56(12). 6719–6731. 9 indexed citations
16.
Chen, Wentao, Qingqing Xu, Xiaoxiao Li, et al.. (2021). Development and application of Cas13a-based diagnostic assay for Neisseria gonorrhoeae detection and azithromycin resistance identification. Journal of Antimicrobial Chemotherapy. 77(3). 656–664. 13 indexed citations
17.
Khurshid, Mohsin, Muhammad Hidayat Rasool, Usman Ali Ashfaq, et al.. (2020). Dissemination of blaOXA-23-harbouring carbapenem-resistant Acinetobacter baumannii clones in Pakistan. Journal of Global Antimicrobial Resistance. 21. 357–362. 34 indexed citations
18.
Wang, Fan, Shunying Yu, Rubai Zhou, et al.. (2020). <p>Variants in the Upstream Region of the Insulin Receptor Substrate-1 Gene Is Associated with Major Depressive Disorder in the Han Chinese Population</p>. Neuropsychiatric Disease and Treatment. Volume 16. 501–507. 2 indexed citations
19.
Ma, Xin, Yan Wang, Zhijun Dai, et al.. (2016). Baicalein suppresses metastasis of breast cancer cells by inhibiting EMT via downregulation of SATB1 and Wnt/β-catenin pathway. SHILAP Revista de lepidopterología. 4 indexed citations
20.
Yin, Xindao, et al.. (2014). The Relationship between Myocardial Bridge Type and Proximal Stenosis in Hypertensive Patients. 23(1). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026